These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32306294)

  • 1. Treatment of moderate-to-severe and active Graves' orbitopathy: a step forward from the OPTIC study.
    Tanda ML; Gallo D; Ippolito S; Bartalena L; Piantanida E
    J Endocrinol Invest; 2020 Oct; 43(10):1523-1525. PubMed ID: 32306294
    [No Abstract]   [Full Text] [Related]  

  • 2. Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.
    Tramunt B; Imbert P; Grunenwald S; Boutault F; Caron P
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):208-213. PubMed ID: 30339291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of graves' orbitopathy after treatment.
    Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M
    Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
    Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal management of Graves orbitopathy: a multidisciplinary approach.
    Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
    Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and Side Effects of Lateral Orbital Wall Decompression Including the Orbital Rim in Patients with Graves' Orbitopathy].
    Horn M; Schittkowski MP
    Klin Monbl Augenheilkd; 2019 Jan; 236(1):17-24. PubMed ID: 30690696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral dysthyroid compressive optic neuropathy responsive to teprotumumab.
    Hwang CJ; Nichols EE; Chon BH; Perry JD
    Eur J Ophthalmol; 2022 May; 32(3):NP46-NP49. PubMed ID: 33525898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endoscopic decompression of orbit in Graves' orbitopathy].
    Poślednik KB; Miśkiewicz P; Jabłońska-Pawlak A; Kantor I; Szczepański MJ
    Pol Merkur Lekarski; 2019 May; 46(275):224-228. PubMed ID: 31152536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and Emerging Treatment Strategies for Graves' Orbitopathy.
    Genere N; Stan MN
    Drugs; 2019 Feb; 79(2):109-124. PubMed ID: 30659423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Graves' orbitopathy].
    Eckstein A; Möller L; Führer D; Oeverhaus M
    Dtsch Med Wochenschr; 2021 Oct; 146(20):1344-1351. PubMed ID: 34644795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial.
    Lanzolla G; Sabini E; Leo M; Menconi F; Rocchi R; Sframeli A; Piaggi P; Nardi M; Marcocci C; Marinò M
    Lancet Diabetes Endocrinol; 2021 Nov; 9(11):733-742. PubMed ID: 34592164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of different treatment modalities for active, moderate-to-severe Graves' orbitopathy: a systematic review and network meta-analysis.
    Li H; Yang L; Song Y; Zhao X; Sun C; Zhang L; Zhao H; Pan Y
    Acta Ophthalmol; 2022 Sep; 100(6):e1189-e1198. PubMed ID: 34918472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified lateral orbital wall decompression in Graves' orbitopathy using computer-assisted planning.
    Spalthoff S; Jehn P; Zimmerer R; Rana M; Gellrich NC; Dittmann J
    Int J Oral Maxillofac Surg; 2018 Feb; 47(2):167-174. PubMed ID: 29096933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Graves' ophthalmopathy.
    González-García A; Sales-Sanz M
    Med Clin (Barc); 2021 Feb; 156(4):180-186. PubMed ID: 33069387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teprotumumab for Graves' orbitopathy and ototoxicity: moving problems from eyes to ears?
    Bartalena L; Marinò M; Marcocci C; Tanda ML
    J Endocrinol Invest; 2022 Jul; 45(7):1455-1457. PubMed ID: 35403994
    [No Abstract]   [Full Text] [Related]  

  • 16. [Perioperative treatment for the urgent orbital decompression surgery in a 30-weeks pregnant woman with Graves' orbitopathy].
    Guerrero-Domínguez R; López-Herrera-Rodríguez D; Domínguez-Blanco A; Medina-de Moya I; Sánchez-Carrillo F
    Rev Esp Anestesiol Reanim; 2014; 61(6):342-5. PubMed ID: 23835254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital decompression in Graves' orbitopathy: efficacy and safety.
    Goh MS; McNab AA
    Intern Med J; 2005 Oct; 35(10):586-91. PubMed ID: 16207257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy.
    Wiersinga WM
    Lancet Diabetes Endocrinol; 2017 Feb; 5(2):134-142. PubMed ID: 27346786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of Graves' orbitopathy: evidence-based recommendations].
    Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
    Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and complications of orbital fat decompression in Graves' orbitopathy: a systematic review and meta-analysis.
    Willaert R; Maly T; Ninclaus V; Huvenne W; Vermeersch H; Brusselaers N
    Int J Oral Maxillofac Surg; 2020 Apr; 49(4):496-504. PubMed ID: 31474503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.